Outcome of Transplantation for Acute Lymphoblastic Leukemia in Children With Down Syndrome

被引:23
|
作者
Hitzler, Johann K. [1 ]
He, Wensheng [2 ]
Doyle, John [1 ]
Cairo, Mitchell [3 ]
Camitta, Bruce M. [4 ]
Chan, Ka Wah [5 ]
Diaz Perez, Miguel A. [6 ]
Fraser, Christopher [7 ]
Gross, Thomas G. [8 ]
Horan, John T. [9 ]
Kennedy-Nasser, Alana A. [10 ]
Kitko, Carrie [11 ]
Kurtzberg, Joanne [12 ]
Lehmann, Leslie [13 ]
O'Brien, Tracey [14 ]
Pulsipher, Michael A. [15 ]
Smith, Franklin O. [16 ]
Zhang, Mei-Jie [2 ]
Eapen, Mary [2 ]
Carpenter, Paul A. [17 ]
机构
[1] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA
[5] Texas Transplant Inst, San Antonio, TX USA
[6] Hosp Nino Jesus, Madrid, Spain
[7] Royal Childrens Hosp, Herston, Qld, Australia
[8] Nationwide Childrens Hosp, Columbus, OH USA
[9] Childrens Healthcare Atlanta Egleston, Atlanta, GA USA
[10] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Duke Univ, Durham, NC USA
[13] Dana Farber Canc Inst, Boston, MA 02115 USA
[14] Sydney Childrens Hosp, Sydney, NSW, Australia
[15] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA
[16] Univ Cincinnati, Inst Canc, Cincinnati, OH USA
[17] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
acute lymhoblastic leukemia; Down syndrome; hematopoietic stem cell transplantation; pediatric; relapse; trisomy; 21; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; TOXICITY; FAILURE; REGIMEN; RELAPSE;
D O I
10.1002/pbc.24918
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than expected for children with DS-ALL (54%) than for non-DS ALL. These data suggest leukemic relapse rather than transplant toxicity is the most important cause of treatment failure. Advancements in leukemia control are especially needed for improvement in HCT outcomes for DS-ALL. Pediatr Blood Cancer 2014;61:1126-1128. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1126 / 1128
页数:3
相关论文
共 50 条
  • [41] Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
    Nachman, James B.
    Heerema, Nyla A.
    Sather, Harland
    Camitta, Bruce
    Forestier, Erik
    Harrison, Christine J.
    Dastugue, Nicole
    Schrappe, Martin
    Pui, Ching-Hon
    Basso, Giuseppe
    Silverman, Lewis B.
    Janka-Schaub, Gritta E.
    BLOOD, 2007, 110 (04) : 1112 - 1115
  • [42] PROGNOSIS AND OUTCOME OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
    PHILIPPE, N
    SOUILLET, G
    PARIS, A
    REVUE DU PRATICIEN, 1986, 36 (37): : 2171 - 2178
  • [43] Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia
    Mehta, Parinda A.
    Zhang, Mei-Jie
    Eapen, Mary
    He, Wensheng
    Seber, Adriana
    Gibson, Brenda
    Camitta, Bruce M.
    Kitko, Carrie L.
    Dvorak, Christopher C.
    Nemecek, Eneida R.
    Frangoul, Haydar A.
    Abdel-Azim, Hisham
    Kasow, Kimberly A.
    Lehmann, Leslie
    Gonzalez Vicent, Marta
    Diaz Perez, Miguel A.
    Ayas, Mouhab
    Qayed, Muna
    Carpenter, Paul A.
    Jodele, Sonata
    Lund, Troy C.
    Leung, Wing H.
    Davies, Stella M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (07) : 1273 - 1277
  • [44] A case of Down syndrome with acute lymphoblastic leukemia and isochromosome Xp
    Baker, JM
    Coppes, MJ
    Roland, B
    CANCER GENETICS AND CYTOGENETICS, 2003, 147 (01) : 75 - 77
  • [45] Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome
    Brown, Austin L.
    de Smith, Adam J.
    Gant, Vincent U.
    Yang, Wenjian
    Scheurer, Michael E.
    Walsh, Kyle M.
    Chernus, Jonathan M.
    Kallsen, Noah A.
    Peyton, Shanna A.
    Davies, Gareth E.
    Ehli, Erik A.
    Winick, Naomi
    Heerema, Nyla A.
    Carroll, Andrew J.
    Borowitz, Michael J.
    Wood, Brent L.
    Carroll, William L.
    Raetz, Elizabeth A.
    Feingold, Eleanor
    Devidas, Meenakshi
    Barcellos, Lisa F.
    Hansen, Helen M.
    Morimoto, Libby
    Kang, Alice Y.
    Smirnov, Ivan
    Healy, Jasmine
    Laverdiere, Caroline
    Sinnett, Daniel
    Taub, Jeffrey W.
    Birch, Jillian M.
    Thompson, Pamela
    Spector, Logan G.
    Pombo-de-Oliveira, Maria S.
    DeWan, Andrew T.
    Mullighan, Charles G.
    Hunger, Stephen P.
    Pui, Ching-Hon
    Loh, Mignon L.
    Zwick, Michael E.
    Metayer, Catherine
    Ma, Xiaomei
    Mueller, Beth A.
    Sherman, Stephanie L.
    Wiemels, Joseph L.
    Relling, Mary V.
    Yang, Jun J.
    Lupo, Philip J.
    Rabin, Karen R.
    BLOOD, 2019, 134 (15) : 1227 - 1237
  • [46] ASPARAGINASE-ASSOCIATED TOXICITY AND HYPERSENSITIVITY REACTIONS IN DOWN SYNDROME CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Van Huynh
    Phillips, Christine
    August, Keith
    Guest, Erin
    Morales, Sonia
    Aftandilian, Catherine
    Winger, Beth
    Agrawal, Anu
    Lin, Carol
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [47] Treating Children With Acute Lymphoblastic Leukemia and Down Syndrome: Pharmacokinetics Provides Insight Into Vincristine Therapy
    Stewart, Clinton F.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (01) : 1 - 2
  • [48] Highly prevalence of the Ph-like signature in acute lymphoblastic leukemia in children with Down syndrome
    Kubota, Yasuo
    Uryu, Kumiko
    Ito, Tatsuya
    Seki, Masafumi
    Kiyokawa, Nobutaka
    Miyano, Satoru
    Ogawa, Seishi
    Terui, Kiminori
    Sato, Atsushi
    Hata, Kenichiro
    Ito, Etsuro
    Takita, Junko
    CANCER SCIENCE, 2018, 109 : 744 - 744
  • [49] Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia
    Bohnstedt, C.
    Levinsen, M.
    Rosthoj, S.
    Zeller, B.
    Taskinen, M.
    Hafsteinsdottir, S.
    Bjorgvinsdottir, H.
    Heymann, M.
    Schmiegelow, K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S104 - S104
  • [50] High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome
    Lundin, Catarina
    Hjorth, Lars
    Behrendtz, Mikael
    Nordgren, Ann
    Palmqvist, Lars
    Andersen, Mette Klarskov
    Biloglav, Andrea
    Forestier, Erik
    Paulsson, Kajsa
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2012, 51 (02): : 196 - 206